Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)

Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)

Abstract Background The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non‐gender CHA2DS2‐VASc scores 0–1. A net clinical benefit (NCB) analysis of ATT may guide stroke prevention strategies i...

Full description

Bibliographic Details
Main Authors: Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Wang‐Soo Lee, Sang Wook Kim, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh, Jin Seok Kim, Jinhee Ahn, So‐Ryoung Lee, Eue‐Keun Choi, Min‐Soo Ahn, Eun Mi Lee, Hwan‐Cheol Park, Ki Hong Lee, Min Kim, Joon Hyouk Choi, Jum Suk Ko, Jin Bae Kim, Changsoo Kim, Gregory Y. H. Lip, Seung Yong Shin, the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF) Investigators
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Journal of Arrhythmia
Subjects:
ABCD score
antithrombotic treatment
atrial fibrillation
net clinical benefit
non‐vitamin K antagonist oral anticoagulant
Online Access:https://doi.org/10.1002/joa3.12840

Internet

https://doi.org/10.1002/joa3.12840

Similar Items